Scholars Central

Review articlePublished 2011

Therapeutic Applications of Monoclonal Antibodies

Authors: Prajapati DS, Shah JS, Dave JB, Patel CN

Systematic Reviews in Pharmacy

Volume 2 · Issue 1 · Pages 37–42

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Monoclonal antibodies drive the development of multibillion dollar biotechnology industry. Many of the pharmaceuticals companies have entered monoclonal antibodies sector, attracted by quicker and less costly development, higher success rates, premium pricing, and potentially reduced threats from generics. The ideal treatment of rheumatoid arthritis (RA) should be safe, produce sustained disease remission and stop radiological damage after a brief course of treatment. If repeated treatments are necessary, they must be safe and economical to use in the long term. It is against these criteria that new treatments for RA, including mAb, should and will be assessed. Monoclonal antibodies are used in the treatment of cancer, including leukemia, colorectal cancer, breast cancer and non-Hodgkin’s lymphoma, RA, ischemic heart disease and transplant rejection. How to Cite this Article Pubmed Style Prajapati DS, Shah JS, Dave JB, Patel CN. Therapeutic Applications of Monoclonal Antibodies. SRP. 2011; 2(1): 37-42. doi:10.4103/0975-8453.83437 Web Style Prajapati DS, Shah JS, Dave JB, Patel CN. Therapeutic Applications of Monoclonal Antibodies. http://www.sysrevpharm.org/?mno=302644609 [Access: March 28, 2021]. doi:10.4103/0975-8453.83437 AMA (American Medical Association) Style Prajapati DS, Shah JS, Dave JB, Patel CN. Therapeutic Applications of Monoclonal Antibodies. SRP. 2011; 2(1): 37-42. doi:10.4103/0975-8453.83437 Vancouver/ICMJE Style Prajapati DS, Shah JS, Dave JB, Patel CN. Therapeutic Applications of Monoclonal Antibodies. SRP. (2011), [cited March 28, 2021]; 2(1): 37-42. doi:10.4103/0975-8453.83437 Harvard Style Prajapati DS, Shah JS, Dave JB, Patel CN (2011) Therapeutic Applications of Monoclonal Antibodies. SRP, 2 (1), 37-42. doi:10.4103/0975-8453.83437 Turabian Style Prajapati DS, Shah JS, Dave JB, Patel CN. 2011. Therapeutic Applications of Monoclonal Antibodies. Systematic Reviews in Pharmacy, 2 (1), 37-42. doi:10.4103/0975-8453.83437 Chicago Style Prajapati DS, Shah JS, Dave JB, Patel CN. "Therapeutic Applications of Monoclonal Antibodies." Systematic Reviews in Pharmacy 2 (2011), 37-42. doi:10.4103/0975-8453.83437 MLA (The Modern Language Association) Style Prajapati DS, Shah JS, Dave JB, Patel CN. "Therapeutic Applications of Monoclonal Antibodies." Systematic Reviews in Pharmacy 2.1 (2011), 37-42. Print. doi:10.4103/0975-8453.83437 APA (American Psychological Association) Style Prajapati DS, Shah JS, Dave JB, Patel CN (2011) Therapeutic Applications of Monoclonal Antibodies. Systematic Reviews in Pharmacy, 2 (1), 37-42. doi:10.4103/0975-8453.83437

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Systematic Reviews in Pharmacy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalSystematic Reviews in Pharmacy
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Prajapati DS”
  • BylineArticles whose byline prints “Shah JS”
  • BylineArticles whose byline prints “Dave JB”
  • BylineArticles whose byline prints “Patel CN”